CTNNB1 and hepatoblastoma: Nevertheless, the mutations in CTNNB1 genes (β-catenin) are most frequently observed in hepatoblastoma patients (Haines et al., 2019) and an increase in cytoplasmic and nuclear immunostaining of β-catenin has been documented in these cases of hepatoblastoma [5,6].